glp-1 agonist common side effects GI Adverse of Glucagon-Like Peptide-1 Receptor Agonists side effects of glp-1 GLP-1

GLP-1 receptor agonist-associated tumor adverse events: A real-world study from 2004 to 2021 based on FAERS

The largest meta-analysis to date, comprising 13 cardiovascular outcome trials involving 83,258 patients with and without diabetes, confirmed that GLP-1 Ras significantly reduced major adverse cardiovascular events (MACEs), all-cause mortality, cardiovascular mortality, fatal and non-fatal strokes, coronary revascularization, and composite kidney outcomes [87]

A lack of investment from the pharmaceutical industry has also stalled research

Kato M, Nakanishi T, Tani T, Tsuda T

doi: 10.3390/ph17070828

The real question isnt just whether they deliver results